Five years clinical outcomes after implantation of Absorb bioresorbable vascular scaffold pilot study in a single center with real world patients, with pre scaffold treatment and guided by intravascular imaging

Abstract

The safety and performance of the Absorb Vascular Scaffold (BVS) (Abbott Vascular, Santa Clara, CA) has been previously demonstrated with clinical data. However, these trials included patients with simple lesions. The Absorb III trial demonstrated an excess of adverse events following BVS implantation. Aiming to evaluate clinical outcomes, we analyzed the treatment of real-world patients in a pilot study from a single center, using optimal technique and intravascular image guidance in all cases, followed during 5 years.